New Therapeutical Approaches
-
Scientific Literature
The Use of Luspatercept for Thalassemia in Adults
Luspatercept is an activin receptor ligand trap that has been shown to enhance late-stage erythropoiesis in animal models of β-thalassemia. A multicenter, international, phase 2 dose-finding study was initiated in…
Read More » -
Scientific Literature
Fair Pricing of Innovative Medicines: An EHA Position Paper
High prices keep innovative medicines out of reach for many patients across Europe, resulting in growing inequalities in accessibility and standards of care. Budgetary pressures compel payers and insurers to…
Read More »